Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women
Authors:
- 1 March 2000
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 81 (3) , 701-708
Abstract
To evaluate the humoral immune response to human papillomavirus (HPV) in women infected with human immunodeficiency virus (HIV), serum samples of 83 HIV-positive individuals were analysed by ELISA for specific antibodies of the isotypes IgG, IgA and IgM recognizing HPV-6, -11, -16, -18 and -31 L1 virus-like particles (VLPs). Papillomavirus-related lesions were present in 30 of 83 HIV-positive women. Twenty-one women (25%) presented with high-/intermediate-grade anogenital squamous intraepithelial lesions. PCR analysis and sequencing for HPV typing was done from biopsy specimens of 18 women; PCR-positive results were obtained in 90% of cases. In addition, HPV DNA hybrid capture assays were performed from cervical swabs of 58 HIV-positive women, 53% of whom had a positive result for high-risk HPV. Overall, positive IgG reactivity to HPV-6/-11 and HPV-16/-18/-31 was seen in 19%/31% and 49%/30%/24% of HIV-positive women, respectively. HPV-seropositivity was even higher than in 48 HIV-negative cervical intraepithelial neoplasia/cancer patients with percentages as follows: 8%/2% and 31%/15%/15%. This difference was significant for HPV-16 (P=0·046). IgA responses were comparable to IgG. IgM responses were low. The extraordinarily high rate of antibodies to the capsid protein L1 of high-risk HPVs (HPV-16, -18 and/or -31) in 58% of HIV-positive women compared to 19% (P=0·00001) of 102 healthy HIV-negative control women suggests a high lifetime cumulative exposure to HPV and increased expression of capsid proteins due to cellular immunodeficiency in HIV-infected women.Keywords
This publication has 27 references indexed in Scilit:
- Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapyAIDS, 1998
- High-Risk Sexual Behavior Among Drug UsersSexually Transmitted Diseases, 1998
- HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: An analysis of HPV genotypesInternational Journal of Cancer, 1997
- Seroprevalence of Human Papillomavirus Types 6 and 16 Capsid Antibodies in Homosexual MenThe Journal of Infectious Diseases, 1997
- The Natural History of Human Papillomavirus Type 16 Capsid Antibodies among a Cohort of University WomenThe Journal of Infectious Diseases, 1996
- Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal AntibodiesVirology, 1996
- Serum IgG, IgM, and IgA Reactivity to Human Papillomavirus Types 11 and 6 Virus-like Particles in Different Gynecologic Patient GroupsThe Journal of Infectious Diseases, 1995
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995
- Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodiesJournal of General Virology, 1994
- Role of HIV as Cofactor in HPV Oncogenesis: In vitro Evidences of Virus Interactions1994